Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Tech News St. Vincent & Grenadines.
Press releases published on June 24, 2025

FluffCo Pillows 2025: This Hotel-Quality Pillow by FluffCo Is Taking Over American Bedrooms
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- In the ever-evolving world of home comfort and sleep science, few brands have captured attention quite like FluffCo. Built on the idea of delivering hotel-quality sleep products to everyday consumers, the …

CovertNest Launches AI-Powered Real Estate Platform to Help International Professionals and First-Time Investors Build Rental Portfolios
San Francisco, CA, June 24, 2025 (GLOBE NEWSWIRE) -- CovertNest today announced the launch of its AI-powered real estate investment platform, designed to help international professionals, first-generation immigrants, and full-time employees build wealth …

Fortrea und Emery Pharma kündigen strategische Zusammenarbeit zur Durchführung FDA-konformer Arzneimittelwechselwirkungsstudien mit Rifampin an
Durham, North Carolina, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (das „Unternehmen“), ein führendes globales Auftragsforschungsinstitut (Contract Research Organization CRO), hat heute eine strategische Zusammenarbeit mit Emery Pharma …

Fortrea et Emery Pharma annoncent une collaboration stratégique visant à mener des études sur les interactions médicamenteuses répondant aux normes de la FDA en utilisant la rifampicine
DURHAM, Caroline du Nord, 24 juin 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE) (la « Société »), une société de recherche contractuelle d’envergure mondiale (CRO) de premier plan, a annoncé aujourd’hui une collaboration stratégique avec Emery Pharma, …

Fortrea & Emery Pharma Umumkan Kolaborasi Strategis untuk Melakukan Studi Interaksi Obat-Obat yang Sesuai Peraturan FDA dengan Menggunakan Rifampin
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Perusahaan”), perusahaan riset berbasis kontrak (CRO) global terkemuka, hari ini mengumumkan kolaborasi strategis dengan Emery Pharma, CRO analitik dan bioanalitik terkemuka yang …

Fortrea y Emery Pharma anuncian colaboración estratégica para realizar estudios de interacción fármaco-fármaco que cumplan con la FDA utilizando rifampicina
DURHAM, Carolina del Norte, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (la "Empresa"), una organización líder mundial en investigación por contrato (CRO), anunció hoy una colaboración estratégica con Emery Pharma, una CRO analítica y …

Fortrea ו-Emery Pharma מכריזות על שיתוף פעולה אסטרטגי לביצוע מחקרי אינטראקציה בין תרופות באמצעות ריפמפיצין, בהתאם לתקני ה-FDA
דורהאם, קרוליינה הצפונית, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (נאסד"ק:FTRE) ("החברה"), חברה שהיא ארגון מחקר מבוסס חוזים (CRO) גלובלית מובילה, הודיעה היום על שיתוף פעולה אסטרטגי עם Emery Pharma, חברת CRO אנליטית וביו-אנליטית מובילה המספקת שירותי בדיקה …

Fortrea dan Emery Pharma Umumkan Kerjasama Strategik untuk Menjalankan Kajian Interaksi Ubat yang Mematuhi Piawaian FDA Menggunakan Rifampin
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“Syarikat”), sebuah organisasi penyelidikan kontrak (CRO) global terkemuka, hari ini mengumumkan kerjasama strategik dengan Emery Pharma, sebuah CRO analitik dan bioanalitik terkemuka …

Fortrea & Emery Pharma Anunciam Colaboração Estratégica para Fornecer Estudos de Interação Medicamentosa Usando Rifampicina em Conformidade com o FDA
DURHAM, N.C., June 24, 2025 (GLOBE NEWSWIRE) -- A Fortrea (Nasdaq: FTRE) (a “Empresa”), uma organização líder global de pesquisa por contrato (CRO), anunciou hoje uma colaboração estratégica com a Emery Pharma, uma CRO analítica e bioanalítica líder que …

フォートリア (Fortrea) とエメリー・ファーマ (Emery Pharma)、リファンピンを用いたFDA準拠の薬物相互作用 (Drug-Drug-Interaction、DDI) 試験を提供するための戦略的提携を発表
ノースカロライナ州ダーラム発, June 24, 2025 (GLOBE NEWSWIRE) -- グローバルな大手医薬品開発業務受託機関 (CRO) であるフォートリア (NASDAQ: FTRE)(以下「同社」) は本日、大手分析・バイオ分析CROとしてcGMPおよびGLPに準拠した試験サービスを提供するエメリー・ファーマとの戦略的提携を発表した。この提携により、薬物相互作用 (DDI) 試験で使用される主要薬剤であるリファンピンに対し、1-メチル-4-ニトロソピペラジン (MNP) …

Fortrea 與 Emery Pharma 宣佈開展戰略合作,使用利福平 (Rifampin) 開展符合 FDA 要求的藥物相互作用試驗
達勒姆,北卡羅來納州, June 24, 2025 (GLOBE NEWSWIRE) -- 全球領先的受託研究機構 (CRO) Fortrea (Nasdaq: FTRE)(下稱「公司」)今天宣佈與 Emery Pharma 建立戰略合作關係。Emery Pharma 是一家領先的分析和生物分析受託研究機構,根據現行的《良好生產規範》(cGMP) 和《藥物非臨床研究品質管理規範》(GLP) 提供測試服務。Fortrea 與 Emery Pharma 的戰略合作將為藥物相互作用 (DDI) …

Fortrea, Emery Pharma와 협력해 FDA 기준에 맞춰 리팜핀 사용 가능한 DDI 연구 지원
노스캐롤라이나주 더럼, June 24, 2025 (GLOBE NEWSWIRE) -- 글로벌 임상시험수탁기관(CRO) Fortrea(나스닥명: FTRE)(이하 “회사”)가 Emery Pharma와 전략적 협력을 발표했다. Emery Pharma는 현행우수제조관리기준(cGMP)과 우수실험실운영기준(GLP)에 맞춰 테스트 서비스를 제공하며 업계를 선도하는 분석 및 생체시료 분석 CRO로, 약물상호작용(DDI) 연구에서 선호되는 리팜핀을 대상으로 로트별 1-메틸 …

Fortrea และ Emery Pharma ประกาศความร่วมมือเชิงกลยุทธ์เพื่อดำเนินการศึกษาวิจัยอันตรกิริยาระหว่างยาที่สอดคล้องกับ FDA โดยใช้ยาไรแฟมปิน (Rifampin…
เดอร์แฮม, รัฐนอร์ทแคโรไลนา, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“บริษัท”) ซึ่งเป็นองค์กรวิจัยตามสัญญา (Contract Research Organization, CRO) ทางคลินิกชั้นนำระดับโลก ได้ประกาศวันนี้ถึงความร่วมมือเชิงกลยุทธ์กับ Emery Pharma ซึ่งเป็น CRO …

Fortrea 与 Emery Pharma 宣布战略合作以开展符合 FDA 规范的利福平药物相互作用研究
北卡罗来纳州达勒姆, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea(纳斯达克代码:FTRE,以下简称“公司”)是一家全球领先的合同研究组织(CRO),今日宣布与分析及生物分析领域领先的合同研究组织 Emery Pharma 建立战略合作。Emery Pharma 提供符合现行良好生产规范(cGMP)和良好实验室规范(GLP)的检测服务。该合作将为药物相互作用(DDI)研究中的首选药物利福平快速按批次进行1-甲基-4-亚硝基哌嗪(MNP …

Free Mining Function Fully Upgraded: RIMining Takes You to Mine Bitcoin BTC, Dogecoin DOGE, and Ethereum ETH With Zero Threshold
Los Angeles, California, June 24, 2025 (GLOBE NEWSWIRE) -- In the new era of digital wealth, who says that mining requires technical skills, mining machines, and high costs? RIMining's newly upgraded "free cloud mining" function is breaking this …

EY US announces Rohit Kapoor of EXL as an Entrepreneur Of The Year® 2025 New York Award winner
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Ernst …

LeptiCell 2025: This Natural Metabolism Support Supplement Gains Momentum in Weight Management Circles, According to Reports
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- In a wellness industry marked by rapid innovation and increasing consumer demand for effective, natural solutions, LeptiCell has emerged as a notable name in the metabolic health space. According to recent …

BioAdaptives Announces National Launch of Pawpa™ Regen
LAS VEGAS , June 24, 2025 (GLOBE NEWSWIRE) -- via IBN -- BioAdaptives, Inc. (OTC Pink: BDPT), an innovator in nutraceutical and wellness science, today announces the upcoming national release of Pawpa™ Regen, a proprietary canine supplement that supports …

Nearly Half of Companies Opt to Pay the Ransom, Sophos Report Finds
OXFORD, United Kingdom, June 24, 2025 (GLOBE NEWSWIRE) -- Sophos, a global leader of innovative security solutions for defeating cyberattacks, today released its sixth annual State of Ransomware report, a vendor-agnostic survey of IT and cybersecurity …

BarxBuddy 2025: This Dog Training Device Gains Momentum Among Pet Owners, According to Reports
Phoenix, AZ, June 24, 2025 (GLOBE NEWSWIRE) -- In a year marked by increasing interest in at-home pet solutions, the BarxBuddy ultrasonic dog training device has gained renewed momentum among pet owners across the United States. This behavioral training …